Filing Details
- Accession Number:
- 0001104659-21-105168
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-08-13 16:46:11
- Reporting Period:
- 2021-08-11
- Accepted Time:
- 2021-08-13 16:46:11
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1124524 | Cryoport Inc. | CYRX | Pharmaceutical Preparations (2834) | 880313393 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1848218 | W Mark Sawicki | C/O Cryoport Inc. 112 Westwood Place, Suite 350 Brentwood TN 37027 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-08-11 | 77,625 | $7.80 | 113,698 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2021-08-11 | 16,577 | $8.65 | 130,275 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-08-11 | 74,453 | $58.37 | 55,822 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-08-11 | 3,172 | $59.11 | 52,650 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-08-11 | 2,521 | $59.83 | 50,129 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Option to purchase common stock | Disposition | 2021-08-11 | 77,625 | $0.00 | 77,625 | $7.80 |
| Common Stock | Option to purchase common stock | Disposition | 2021-08-11 | 16,577 | $0.00 | 16,577 | $8.65 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2025-05-07 | No | 4 | M | Direct | |
| 51,423 | 2028-03-28 | No | 4 | M | Direct |
Footnotes
- 1/48 of the 77,625 options originally granted vested on the 7th of each month for forty-eight months beginning June 7, 2015.
- 1/48 of the 68,000 options originally granted vested on the 28th of each month for forty-eight months beginning April 28, 2018.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.85 to $58.84, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.85 to $59.51, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.81 to $59.90, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
Billionaire Hedge Funds
